» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Indigenous Health in Medicine Program Manager looks to build and strengthen connections
- Researchers from Dalhousie and IWK Health Centre Receive $4.8 Million in Funding from Genome Canada
- Dal contributes to first ever Lancet Child and Adolescent Health Commission
- Molly Appeal: Maritime researchers pioneering technology in early diagnosis of Alzheimer's disease
- Excluding pregnant women from COVID‑19 vaccine trials puts their health at risk
- Partnering to improve health outcomes at patient and population levels across the Maritimes
- Making Space, Elevating Voices: Dal Community Members take part in Scholar Strike
- Program provides solution for keeping doctors in rural areas